← All stocks

Cartesian Therapeutics, Inc.

RNAC Net selling

CIK 0001453687 #3561 in the set updated 17 Sep 2026

Bought (12 mo)

$205.80K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$258.67K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$258.67K

3 of 3 sales

Net

−$52.87K

−$52.87K against sales at will

By person

17 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BARABE TIMOTHY C

Director

$205.80K (1)

—

+$205.80K

56,966

0.1883%

$388.49K

+161.7%

Brunn Carsten

President and CEO

—

$162.08K (1)

−$162.08K

323,530

1.07%

$2.21M

+97.4%

Davis Blaine

Chief Financial Officer

—

$72.23K (1)

−$72.23K

121,220

0.4007%

$826.68K

+50.0%

Miljkovic Milos

Chief Medical Officer

—

$24.37K (1)

−$24.37K

58,820

0.1944%

$401.13K

+221.9%

SPRINGER TIMOTHY A

Director

—

9,302,798

30.75%

$63.44M

+11.4%

Kalayoglu Murat

10% owner

—

5,824,838

19.25%

$39.72M

+64.4%

Hoge Elizabeth

10% owner

—

5,313,261

17.56%

$36.23M

+75.0%

English Emily

Chief Operations Officer

—

94,226

0.3114%

$642.59K

+415.7%

Jewell Christopher M

Chief Scientific Officer

—

62,490

0.2065%

$426.16K

+140.9%

Kurtoglu Metin

Chief Technology Officer

—

62,258

0.2058%

$424.58K

+22.0%

Singer Michael

Director

—

49,578

0.1639%

$338.11K

−58.6%

COX CARRIE SMITH

Director

—

15,629

0.0517%

$106.59K

+20.0%

ZENNER PATRICK J

Director

—

12,974

0.0429%

$88.48K

+66.9%

DeSilva Nishan M

Director

—

11,366

0.0376%

$77.51K

+84.3%

Malik Kemal

Director

—

11,133

0.0368%

$75.92K

+87.6%

Seymour June Ann

Chief Accounting Officer

—

6,500

0.0215%

$44.33K

—

Bot Adrian Ion

Director

—

5,800

0.0192%

$39.55K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Davis Blaine

6 Jan 2026

Chief Financial Officer

Sell

10,591

$6.82

$72.23K

Miljkovic Milos

6 Jan 2026

Chief Medical Officer

Sell

3,573

$6.82

$24.37K

Brunn Carsten

6 Jan 2026

President and CEO

Sell

23,766

$6.82

$162.08K

Show all 6 transactions →

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 1,819,257

History held since 21 Dec 2016